Perspectives on IP strategy, patent valuation, structured invention, and the evolving landscape of intellectual property from the team at ipCapital Group.
Let's discuss how ipCapital Group can help you build, protect, and monetize your intellectual property portfolio.
Talk with Our Team
EHRs now bundle ambient scribing at near-zero cost while regulators prepare oversight on clinical AI. The durable advantage shifts from better notes to governed, multi-agent workflow orchestration that compresses admin time and withstands audits.
Patent signals reveal a surprising white space in GPU scheduling and virtualization, opening room to build, differentiate, and protect the next compute layer.
A short window has opened to secure strategic positions in edge-run motion planning, measured in months, not years. The advantage will accrue to teams that turn runtime architecture into product and IP.
Unified, agentic architectures are becoming ad tech’s control plane. Advantage is shifting from features to the decisioning fabric that orchestrates creative, media, and measurement, before it becomes commodity infrastructure.
Why the winners in Face AI will fuse on-device intelligence, demographic fairness, and privacy-preserving tracking, and lock it in with strategic product and IP positions.
A market-facing look at the accelerating patent race in multi-agent AI, the unclaimed white space in orchestration and evaluation, and the product and IP moves that build a durable moat.
Antora’s $550 million round landed in a patent field 54,623 families deep and about fifty years old. The only part of it still bending is thermal storage tied to data centers.
The orbital service layer spans space awareness, rendezvous, servicing, and in-space assembly. A patent landscape shows where the technical and IP positions are forming.
Over 7,000 AI cybersecurity patents filed since 2018, and in 2025 autonomous systems overtook human-in-the-loop. The agentic blueprint already exists.
AI can spot heart disease in a mammogram, but cross-diagnostic inference patents are under 1% of AI medical imaging filings, a wide-open white space.
Cross-domain AI patents are a rising freedom-to-operate risk in medtech. Nvidia holds 185 medical AI patents, none cancer-specific, yet many overlap.
PLD Space raised $209M, but reusable launch vehicle patents show ArianeGroup, Blue Origin, and Stoke Space already own the technical ground.